| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| OUTPAT | OUTPAT_ICD10(C811) | Nodular sclerosis | 516 | |
| OUTPAT | OUTPAT_ICD10(C819) | Hodgkin's disease, unspecified | 341 | |
| INPAT | INPAT_ICD10(C811) | Nodular sclerosis | 305 | |
| INPAT | INPAT_ICD10(C819) | Hodgkin's disease, unspecified | 204 | |
| OUTPAT | OUTPAT_ICD10(C810) | Lymphocytic predominance | 204 | |
| OUTPAT | OUTPAT_ICD10(C817) | Other Hodgkin's disease | 149 | |
| OUTPAT | OUTPAT_ICD10(C812) | Mixed cellularity | 143 | |
| INPAT | INPAT_ICD10(C810) | Lymphocytic predominance | 100 | |
| INPAT | INPAT_ICD10(C812) | Mixed cellularity | 86 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C811) | Nodular sclerosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 76 | |
| INPAT | INPAT_ICD10(C817) | Other Hodgkin's disease | 75 | |
| INPAT | INPAT_ICD9(2015X) | Hodgkin's disease, Nodular sclerosis | 52 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C819) | Hodgkin's disease, unspecified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 49 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C81) | Hodgkin's disease. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 38 | |
| INPAT | INPAT_ICD9(2019X) | Hodgkin's disease, unspecified type | 37 | |
| OUTPAT | OUTPAT_ICD10(C813) | Lymphocytic depletion | 24 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C817) | Other Hodgkin's disease. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 22 | |
| INPAT | INPAT_ICD9(2016A) | Hodgkin's disease, mixed cellularity | 21 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C812) | Mixed cellularity. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 21 | |
| INPAT | INPAT_ICD9(2014A) | Hodgkin's disease, Lymphocytic-histiocytic predominance | 20 | |
| DEATH | DEATH_ICD10(C811) | Nodular sclerosis | 19 | |
| INPAT | INPAT_ICD9(2015A) | Hodgkin's disease, Nodular sclerosis | 17 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C810) | Lymphocytic predominance. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 16 | |
| INPAT | INPAT_ICD10(C813) | Lymphocytic depletion | 13 | |
| DEATH | DEATH_ICD10(C819) | Hodgkin's disease, unspecified | 12 | |
| OUTPAT | OUTPAT_ICD10(C81) | Hodgkin's disease | 9 | |
| INPAT | INPAT_ICD9(2014X) | Hodgkin's disease, Lymphocytic-histiocytic predominance | 7 | |
| INPAT | INPAT_ICD9(2017X) | Hodgkin's disease, Lymphocytic depletion | 7 | |
| DEATH | DEATH_ICD10(C812) | Mixed cellularity | 6 | |
| DEATH | DEATH_ICD10(C810) | Lymphocytic predominance | 5 |